Urine biomarkers of lupus nephritis pathology and response to therapy

狼疮性肾炎病理学的尿液生物标志物和治疗反应

• 批准号: 8195962
• 负责人: JAMES C OATES
• 金额: --
• 依托单位: RALPH H JOHNSON VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2014-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8195962
• 关键词: Acute Renal Failure with Renal Papillary Necrosis; Address; Adrenal Cortex Hormones; Affect; African American; American; Antigen-Antibody Complex; Automobile Driving; Baltimore; Biological Assay; Biological Markers; Biological Neural Networks; Biopsy; Blood Pressure; Caucasians; Caucasoid Race; Characteristics; Classification; Clinic; Clinical; Clinical Trials; Color; Complement; Complex; Consensus; Coupled; Cyclophosphamide; Data; Decision Making; Detection; Development; Diabetes Mellitus; Diagnosis; Diagnostic; Disease; Disease Marker; Drug toxicity; Electron Microscopy; Elements; Enzyme-Linked Immunosorbent Assay; Excretory function; Exposure to; Female; Fibrosis; Funding; Future; Glomerulonephritis; Goals; Gold; Growth Factor; Health; Heterogeneity; High Pressure Liquid Chromatography; Histopathology; Hypertension; Immune response; Immunoassay; Individual; International; Intravenous; Kidney; Kidney Diseases; Kidney Failure; Lesion; Link; Literature; Logistic Regressions; Lupus Nephritis; Machine Learning; Measures; Mediating; Methods; Minority; Modeling; Monitor; Nature; Neoadjuvant Therapy; Nephritis; Nephrology; Online Systems; Oral; Outcome; Outcome Measure; Oxidative Stress; Pathogenesis; Pathology; Pathway Analysis; Pathway interactions; Patient Care; Patients; Performance; Phase; Physiologic pulse; Population; Population Study; Post-Translational Protein Processing; Preparation; Principal Investigator; Process; Production; Proliferative Glomerulonephritis; Proteins; Qualifying; Regression Analysis; Renal function; Research; Research Personnel; Rheumatology; Severity of illness; Societies; Staging; Study models; System; Systemic Lupus Erythematosus; Techniques; Technology; Testing; Therapeutic; Time; Training; Treatment Failure; Treatment Protocols; Tyrosine; Urine; Validation; Veterans; Woman; Work; base; candidate marker; chemokine; clinical decision-making; cohort; college; cytokine; design; drug development; health disparity; mathematical model; meetings; novel; novel strategies; patient population; population health; predictive modeling; prevent; programs; prospective; response; rheumatologist; standard care; therapeutic target; tool; treatment response; urinary